Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2017 Jul 25;23(11):1887–1894. doi: 10.1016/j.bbmt.2017.07.014

Figure 4.

Figure 4

OS (A) and EFS (B) by exposure to new haplotype. The median survival was 552 days (95% CI 376–2950+) in the group transplanted with a second graft that did not harbor a new mismatched haplotype, while it was not reached in the group whose allograft contained a new mismatched haplotype (HR 0.36, 95% CI 0.14 – 0.9; p=0.02). The median event free survival was also longer in the group who received an allograft containing a new mismatched haplotype (NR versus 401 days, HR 0.50, 95% CI .22–1.14, p=0.09)